BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19111674)

  • 1. Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness.
    Tran TA; Gillet L; Roger S; Besson P; White E; Le Guennec JY
    Biochem Biophys Res Commun; 2009 Feb; 379(2):304-8. PubMed ID: 19111674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231.
    Froidevaux-Klipfel L; Poirier F; Boursier C; Crépin R; Poüs C; Baudin B; Baillet A
    Proteomics; 2011 Oct; 11(19):3877-86. PubMed ID: 21761557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L; Menendez JA; Liu H; Lupu R
    Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT; Yu D; Hung MC
    Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
    Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
    Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells.
    Wang L; Ling Y; Chen Y; Li CL; Feng F; You QD; Lu N; Guo QL
    Cancer Lett; 2010 Nov; 297(1):42-8. PubMed ID: 20580866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro exposure to paclitaxel modulates integrin expression by human T lymphocytes and inhibits T cell adhesion to breast carcinoma cells.
    Bhan V; Mader JS; Hoskin DW
    Oncol Rep; 2004 Apr; 11(4):893-7. PubMed ID: 15010891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
    Lee HS; Seo EY; Kang NE; Kim WK
    J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
    Fang M; Liu B; Schmidt M; Lu Y; Mendelsohn J; Fan Z
    Anticancer Res; 2000; 20(1A):103-11. PubMed ID: 10769641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells.
    Isbilen B; Fraser SP; Djamgoz MB
    Int J Biochem Cell Biol; 2006; 38(12):2173-82. PubMed ID: 16931105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
    Yu D; Liu B; Tan M; Li J; Wang SS; Hung MC
    Oncogene; 1996 Sep; 13(6):1359-65. PubMed ID: 8808711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae.
    Brisson L; Gillet L; Calaghan S; Besson P; Le Guennec JY; Roger S; Gore J
    Oncogene; 2011 Apr; 30(17):2070-6. PubMed ID: 21170089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
    Wiesen KM; Xia S; Yang CP; Horwitz SB
    Cancer Lett; 2007 Nov; 257(2):227-35. PubMed ID: 17869412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
    J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.
    Reshkin SJ; Bellizzi A; Cardone RA; Tommasino M; Casavola V; Paradiso A
    Clin Cancer Res; 2003 Jun; 9(6):2366-73. PubMed ID: 12796407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
    Zhou Y; Inaba S; Liu J
    Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells.
    Fawcett H; Mader JS; Robichaud M; Giacomantonio C; Hoskin DW
    Int J Oncol; 2005 Dec; 27(6):1717-26. PubMed ID: 16273228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.